Infectious Diseases (all articles)
Respiratory Support in Novel Coronavirus Disease (COVID-19) Patients, with a Focus on Resource-Limited Settings
24 Apr, 2020 | 03:48h | UTC
Observational Study: Renin-Angiotensin System Inhibitors are Not Associated with Severity or Mortality in Hospitalized Patients with Coronavirus Disease
24 Apr, 2020 | 03:46h | UTCCommentary: Drugs for high blood pressure don’t appear to make COVID-19 worse – Science News
New York Antibody Study Estimates 14% of Residents in State and 20% in NYC Have Had Covid-19
24 Apr, 2020 | 03:44h | UTC- NY releases figures estimating 14 percent in state, 20 percent in NYC have had COVID-19 – The Hill
- New York antibody study estimates 13.9% of residents have had the coronavirus, Gov. Cuomo says – CNBC
- 1 in 5 New Yorkers May Have Had Covid-19, Antibody Tests Suggest – The New York Times
- Coronavirus Has Infected A 5th Of New York City, Testing Suggests – NPR
- New York Finds Virus Marker in 13.9%, Suggesting Wide Spread – Bloomberg
Perspective: Against Pandemic Research Exceptionalism
24 Apr, 2020 | 03:39h | UTCAgainst pandemic research exceptionalism – Science
“Crises are no excuse for lowering scientific standards.”
Health Care Workers Seek to Flatten COVID-19’s ‘Second Curve’—Their Rising Mental Anguish
24 Apr, 2020 | 03:42h | UTCHealth care workers seek to flatten COVID-19’s ‘second curve’—their rising mental anguish – Science
Related: Understanding and Addressing Sources of Anxiety Among Health Care Professionals During the COVID-19 Pandemic – JAMA AND Mental health outcomes among front and second line health workers associated with the COVID-19 pandemic in Italy. – medRxiv AND Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019 – JAMA Network Open
“there’s a second curve we’re going to have to flatten: the mental health consequences of the pandemic.”
A Skeptic’s Guide To Ecologic Studies During A Pandemic
24 Apr, 2020 | 03:34h | UTCA Skeptic’s Guide To Ecologic Studies During A Pandemic – Forbes
Related: BCG Against Coronavirus: Less Hype And More Evidence, Please – Forbes
Debate: Is it Wrong to Prioritize Younger Patients with Covid-19?
24 Apr, 2020 | 03:30h | UTCIs it wrong to prioritise younger patients with covid-19? – The BMJ
Commentary: Should age be a prioritizing factor in deciding who gets treated for COVID-19? – News Medical
Perspective: In Defense of Evidence-Based Medicine for the Treatment of COVID-19 ARDS
24 Apr, 2020 | 03:36h | UTC
New Data on Remdesivir: No benefit for Patients with Covid-19
24 Apr, 2020 | 03:31h | UTCRelated: Remdesivir in covid-19 – The BMJ AND What’s Happening With Remdesivir? – Science Translational Medicine AND Slow down your giddyup on Gilead news – Health News Review
Hydroxychloroquine and Coronavirus: A Guide to the Scientific Studies so Far
24 Apr, 2020 | 03:28h | UTCHydroxychloroquine and coronavirus: a guide to the scientific studies so far – The Guardian
IHME Report: Forecasting the Impact of the First Wave of the COVID-19 Pandemic on Hospital Demand and Deaths for the USA and European Economic Area Countries
24 Apr, 2020 | 03:29h | UTCSee full report: Forecasting the impact of the first wave of the COVID-19 pandemic on 2 hospital demand and deaths for the USA and European Economic Area 3 countries
Community-acquired Pneumonia: Strategies for Triage and Treatment
24 Apr, 2020 | 03:20h | UTC
[Abstract Only] Randomized Trial: Antibiotics Do Not Reduce Length of Hospital Stay for Uncomplicated Diverticulitis
24 Apr, 2020 | 03:23h | UTCAntibiotics Do Not Reduce Length of Hospital Stay for Uncomplicated Diverticulitis in a Pragmatic Double-Blind Randomized Trial – Clinical Gastroenterology and Hepatology (link to abstract – $ for full-text)
Related: Treatment of Uncomplicated Acute Diverticulitis Without Antibiotics: A Systematic Review and Meta-analysis – Diseases of the Colon & Rectum (link to abstract – $ for full-text) AND Randomized Trial: Antibiotic Avoidance Associated with Similar Long-term Outcomes in Uncomplicated Diverticulitis (randomized trials on the subject)
CDC Guidance: Preexposure Prophylaxis for Prevention of HIV Acquisition Among Adolescents
24 Apr, 2020 | 03:19h | UTC
Systematic Review: SARS-CoV-2 Infection in Children and Adolescents
23 Apr, 2020 | 09:40h | UTCCommentaries: Most kids with coronavirus usually recover within two weeks, JAMA study finds – CNBC AND Young people at lower risk for COVID-19, can still transmit the virus – UPI AND Expert reaction to systematic review of COVID-19 in children – Science Media Centre
Clinical Features and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
23 Apr, 2020 | 09:43h | UTC
Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection
23 Apr, 2020 | 09:41h | UTCAlterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection – JAMA
Related: Study Validates Loss of Smell and Taste as Symptoms of Covid-19
[Preprint] Study: Saliva is More Sensitive for SARS-CoV-2 Detection in COVID-19 Patients than Nasopharyngeal Swabs
23 Apr, 2020 | 09:36h | UTC
COVID-19 in Children in the United States
23 Apr, 2020 | 09:38h | UTCCommentaries: The coronavirus has probably infected far more children in the US than thought, a study says – Business Insider AND COVID-19 possibly striking more children than expected – University of South Florida
Opinion: A Call for Rational Intensive Care in the Era of COVID-19
23 Apr, 2020 | 09:34h | UTC
Editorial: Remdesivir in Covid-19
23 Apr, 2020 | 09:35h | UTCRemdesivir in covid-19 – The BMJ
Related: What’s Happening With Remdesivir? – Science Translational Medicine AND Slow down your giddyup on Gilead news – Health News Review
Cochrane Review Confirms Effectiveness and Safety of MMR vaccines
23 Apr, 2020 | 09:24h | UTCVaccines for measles, mumps, rubella, and varicella in children – Cochrane Library
News Release: Cochrane Review confirms effectiveness of MMR vaccines – Cochrane Library
NIH COVID-19 Treatment Guidelines
22 Apr, 2020 | 09:02h | UTCNIH Coronavirus Disease 2019 (COVID-19) Treatment Guidelines – National Institutes of Health
News Release: Expert U.S. panel develops NIH treatment guidelines for COVID-19
Commentary: New U.S. Treatment Guidelines for Covid-19 Don’t See Much Progress – The New York Times
Antibody Surveys Suggesting Vast Undercount of Coronavirus Infections may be Unreliable
22 Apr, 2020 | 08:57h | UTCAntibody surveys suggesting vast undercount of coronavirus infections may be unreliable – Science
[Preprint] Observational Study: No Benefit from Hydroxychloroquine in Patients Hospitalized with Covid-19
22 Apr, 2020 | 08:58h | UTCOutcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19 – medRxiv
Commentaries: Study finds no benefit, higher death rate in patients taking hydroxychloroquine for Covid-19 – CNN AND More deaths, no benefit from malaria drug in VA virus study – Associated Press